Posted AT 5:00 PM EDT on 23/07/08
Gene tied to muscle weakness from cholesterol drugs
BOSTON — British researchers have located a gene responsible for muscle pain or weakness experienced by some people taking statin drugs to fight “bad” cholesterol, they reported on Wednesday.
The discovery could lead to routine testing to identify patients who should be given a different class of drug, or those who should be kept on a lower dose.
The full text of this article has 479 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
Choosing silence 
- 'Why not just talk about it?'
- Abortion has been unrestricted in Canada for two decades, but few women who make the choice ever talk about it
72
-
In Pictures:
Speaking out 
Breakdown
- Our mental health crisis
- Globe series tackles stigma, tells stories of Canadians
Child's View
- Focus on malaria
- Scenes from life in Liberia
Earlier discussion
slideshow
- Medical marijuna
- Alison Myrden's painful battle with MS
Features
- Confronting cancer
- Globe Series concludes with look at people who blaze trails
- Battling cancer
- Breast cancer death rates declining
-
Special report:
A day in the life
In pictures
- Best position in bed
- How you sleep can make you feel better or worse
